Abbott Q1 2026 Earnings: Revenue Beats $11.16 Billion as Exact Sciences Deal Reshapes Outlook
Quick Verdict: Abbott reported Q1 2026 net sales of $11.164 billion and GAAP diluted EPS of $0.61, with adjusted EPS of $1.15 growing 6% year over year. Revenue modestly beat consensus while EPS was roughly in line, and early reports indicate a muted to slightly negative stock reaction on cautious guidance tied to the Exact Sciences acquisition. About Abbott Abbott …